Entity Details

Primary name AMHR2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ16671
EntryNameAMHR2_HUMAN
FullNameAnti-Muellerian hormone type-2 receptor
TaxID9606
Evidenceevidence at protein level
Length573
SequenceStatuscomplete
DateCreated2000-12-01
DateModified2021-06-02

Ontological Relatives

GenesAMHR2

GO terms

Show/Hide Table
GOName
GO:0001880 Mullerian duct regression
GO:0004674 protein serine/threonine kinase activity
GO:0005026 transforming growth factor beta receptor activity, type II
GO:0005524 ATP binding
GO:0005886 plasma membrane
GO:0006468 protein phosphorylation
GO:0007179 transforming growth factor beta receptor signaling pathway
GO:0007548 sex differentiation
GO:0008584 male gonad development
GO:0008585 female gonad development
GO:0017002 activin-activated receptor activity
GO:0030509 BMP signaling pathway
GO:0032924 activin receptor signaling pathway
GO:0042562 hormone binding
GO:0043235 receptor complex
GO:0046872 metal ion binding
GO:0048179 activin receptor complex
GO:0048185 activin binding
GO:0071363 cellular response to growth factor stimulus
GO:1990262 anti-Mullerian hormone signaling pathway
GO:1990272 anti-Mullerian hormone receptor activity

Subcellular Location

Show/Hide Table
Subcellular Location
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000333 Ser/Thr protein kinase, TGFB receptorFamilyFamily
IPR000472 Activin types I and II receptor domainDomainDomain
IPR000719 Protein kinase domainDomainDomain
IPR011009 Protein kinase-like domain superfamilyFamilyHomologous superfamily
IPR015771 Anti-muellerian hormone receptor, type IIFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
261550 OMIMPersistent Muellerian duct syndrome 1 (PMDS1)A form of male pseudohermaphroditism characterized by a failure of Muellerian duct regression in otherwise normal males. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00171 ATPDrugbanksmall molecule